Achieve life sciences announces critical milestone successfully reached in orca-ol cytisinicline clinical trial required for nda submission

Over 300 participants have completed cumulative six months of cytisinicline treatment in the orca-ol trial, completing the long-term exposure requirement for nda submission

ACHV Ratings Summary

ACHV Quant Ranking